PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Health & social (CPV 85)›
  4. Roche Diagnostics Ltd
RD

Roche Diagnostics Ltd

Health & social · West Sussex
Large

Roche Diagnostics Ltd focuses on developing tests and treatments for serious diseases, including pharmaceuticals and diagnostic solutions. They aim to improve patient outcomes through scientific innovation and partnerships.

roche.co.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£727.6m
Live
90
Buyers
73
12m
£236.2m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities6
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts90 / 167
  • Top buyers73
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Roche Diagnostics LtdUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Roche Diagnostics Ltd has won £727.6m across 73 public-sector buyers, with 90 live contracts. No active Companies House risk flags.

Why: top buyer Department of Health and Social Care (T&T) at 19% · 88% in Health & social · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
90 of 167Live contracts
19%Top-buyer concentration
88%Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value · 1/5

Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.

◐ From supplier website
JobsNo commitment stated✓
SkillsNo commitment stated✓
Environment1 commitment ↗✓
Tackling inequalityNo commitment stated✓
CommunityNo commitment stated✓
Environment · 1
  • WebsiteSustainabilityRoche contributes to improving outcomes for patients through transformative medicines and diagnostic solutions.

Extracted automatically from roche.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 2
Pharmaceutical SolutionsDevelopment and availability of treatments for serious diseases. ↗Diagnostic SolutionsDevelopment of diagnostic tests, instruments, and digital solutions for healthcare professionals. ↗
Frameworks & DPS · 6 from notices
  • National Microbiology Framework - Lot 1: Diagnostic Goods and ServicesPublic Health England · £25.6m
  • CLINICAL MANAGED SERVICES, INCLUDING MANAGED MAINTENANCE SERVICES (SBS10251)N H S Shared Business Services · £17.7m
  • Digital Diagnostic SolutionsSUPPLY CHAIN COORDINATION LIMITED · £13.0m
  • Medical ITNHS Supply Chain : NHS Supply Chain · £8.1m
  • Managed Laboratory Contract for Cellular PathologyNorth of England Commercial Procurement Collaborative (NOE CPC) · £3.7m
  • HEV NAT Managed Service ContractNHS Blood & Transplant (NHSBT) · £3.5m

Extracted automatically from roche.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 90 live · 77 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Provision of genomic profiling testing of solid tumours and liquid CDX (Foundation One)
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£122k2 yrspending
Pathology Managed Service for Midlands & East 2 Network
NORTHERN LINCOLNSHIRE AND GOOLE NHS FOUNDATION TRUST CHARITABLE FUNDS AND OTHER RELATED CHARITIES8511180004 Jun 2026£58.0m12 yrsLive
Pathology Managed Service for Midlands & East 2 Network
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST8511180004 Jun 2026£25.0m10 yrsLive
Pathology Managed Service for Midlands & East 2 Network
KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST8511180004 Jun 2026£13.0m10 yrsLive
Pathology Managed Service for Midlands & East 2 Network
Northampton General Hospital NHS Trust8511180004 Jun 2026£14.0m10 yrsLive
Procurement reference Pathology Managed Service for Midlands & East 2 Network
University Hospitals of Derby and Burton NHS Foundation Trust8511180004 Jun 2026£45.0m10 yrsLive
Pathology Managed Service for Midlands & East 2 Network
University Hospitals of Leicester NHS Tr8511180004 Jun 2026£32.0m10 yrsLive
Pathology Managed Service for Midlands & East 2 Network
Sherwood Forest Hospitals Trust8511180004 Jun 2026£14.0m9.8 yrsLive
0P001960 To supply and install Benchmark special stains systems at RSCH & SRH
University Hospitals Sussex NHS Foundation Trust3800000031 Mar 2026£61k12 moLive
Roche - Point of Care Testing (POCT) Managed Service Contract
Norfolk and Norwich University Hospitals NHS Foundation Trust8511180001 Feb 2026£5.4m7 yrsLive
Total live value £383.8m · mean award £4.4m1–10 of 167

Top buyers · 73 buyers · top 3 = 46%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
Department of Health and Social Care (T&T)
4 contracts
19%
since 2021
2
Gateshead Health NHS Foundation Trust
2 contracts
15%
since 2023
3
Public Health England
16 contracts
12%
since 2016
4
UK HEALTH AND SECURITY AGENCY
21 contracts
10%
since 2021
5
NORTHERN LINCOLNSHIRE AND GOOLE NHS FOUNDATION TRUST CHARITABLE FUNDS AND OTHER RELATED CHARITIES
1 contract
8%
since 2026
6
University Hospitals of Derby and Burton NHS Foundation Trust
5 contracts
6%
since 2026
7
University Hospitals of Leicester NHS Tr
3 contracts
5%
since 2021
8
Gloucestershire Hospitals NHS Foundation Trust
1 contract
3%
since 2025
9
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST
2 contracts
3%
since 2026
10
N H S Shared Business Services
2 contracts
2%
since 2024

Category mix

CPV-division share of last-12m awarded value. Single-category exposure: 88%.

✓ From notices
Health & social85
88%
Architecture & engineering71
11%
Laboratory equipment38
0%
Installation services51
0%
⚠ Concentration: 88% of recent awarded value sits in a single CPV division. A category-specific downturn would materially affect revenue.

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
North East5 contracts
29%
London26 contracts
27%
East Midlands13 contracts
26%
South West8 contracts
8%
Yorkshire10 contracts
7%
Eastern12 contracts
2%
West Midlands16 contracts
1%
South East3 contracts
0%
Wales7 contracts
0%
Scotland14 contracts
0%
Northern Ireland4 contracts
0%
North West1 contract
0%
Region resolved for 53% of awarded value (by buyer postcode); the remainder lacks a usable address.

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Roche Diagnostics Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
RD
Roche Diagnostics Ltd
No£236.2m—
TC
Topcoat Construction Limited / TCL Group
Yes£67.6m2
IW
Ian Williams
No£67.6m2
WH
Westone Housing
Yes£67.6m2
ER
EQUANS Regeneration Limited
No£67.6m2
CH
C Hanlon Facilities Management Ltd
Yes£67.6m2
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Due in -31d
Next due 13 Jun 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
00571546
Status
Active
Type
Private limited
Incorporated
14 Sept 1956
Reg. office
Roche House, Charles Avenue, Burgess Hill, West Sussex, RH15 9RY
SIC codes
74909
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • PAMBA, Allan — director
    Appointed 01 Apr 2026
  • ROWBOTHAM, Kathryn Ryan — director
    Appointed 02 Nov 2025
  • UL HAQ, Muhammad Omair — director
    Appointed 01 Nov 2025
  • PAWAN, Catherine Sarah — secretary
    Appointed 20 Jan 2021
  • Roche Holding (Uk) Limited — person with significant control
    ownership of shares 75 to 100 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
ROCHE DIAGNOSTICS LIMITED
00571546 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.